Drug intelligence / Profile preview

VipaCla

Development stage: Unknown
Lead developer: Royal Medicalink Pharmalab
Modality: Small Molecules
Administration: Oral

Overview

VipaCla is an Indonesian traditional medicine and consumer health supplement developed and manufactured by Royal Medicalink Pharmalab. It is formulated from the extract of *Clarias batrachus* (walking catfish), a species known for its high content of albumin and essential amino acids. The product is primarily marketed to support the maintenance of healthy albumin levels, aid in the recovery process following surgery or illness, and promote wound healing. As a traditional medicine (Obat Tradisional), it is registered with the Indonesian Food and Drug Authority (BPOM) and produced in compliance with CPOTB (Indonesian Good Manufacturing Practice for Traditional Medicine) and Halal certification standards.

Brand names: VipaCla

Beyond the preview

Go deeper on VipaCla.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on VipaCla.

Explore the full profile